Rituximab, an Anti-CD20 Monoclonal Antibody: History & Mechanism: Conclusion Rituximab, approved for treatment of B-cell lymphoma in adults, is being used experimentally in various immune-related diseases, PTLD, and the prevention and treatment of acute rejection. A need for controlled clinical trials is indicated before the wides
Rituximab: a new therapeutic monoclonal antibody for non-Hodgkin's lymphoma. 1. Cancer Pract. 1998 May-Jun;6(3):195-7. Rituximab: a new therapeutic monoclonal antibody for non-Hodgkin's lymphoma. Scott SD. University of Iowa College of Pharmacy, Division of Clinical and Administrative Pharmacy, Iowa City, USA. Rituximab is an effe
rituximab單株抗體 - 相關部落格
Treatment of relapsed CD20+ Hodgkin lymphoma with the monoclonal antibody rituximab is effective and 1. Blood. 2003 Jan 15;101(2):420-4. Treatment of relapsed CD20+ Hodgkin lymphoma with the monoclonal antibody rituximab is effective and well tolerated: results of a phase 2 trial of the German Hodgkin Lymphoma Study Group. Rehwald U, Schulz H, Reiser M .
Rituximab - WebMD - Better information. Better health. Rituximab is available for intravenous (IV) use. How It Works Rituximab belongs to a group of medicines known as monoclonal antibodies. It is designed to recognize specific proteins that are found on the surface of some lymphoma cells. The monoclonal anti
Rituximab - National Cancer Institute This page contains brief information about rituximab and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials. ... Rituximab (rih-TUK-sih-mab) This page contains brief information about rituxi
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of pat PURPOSE The CD20 antigen is expressed on more than 90% of B-cell lymphomas. It is appealing for targeted therapy, because it does not shed or modulate. A chimeric monoclonal antibody more effectively mediates host effector functions and is ...
Rituxan - Rituximab - Dosage - Side Effects - Interactions - Warnings Rituxan (Rituximab, MabThera) drug information, dosage, side effects, drug interactions, and warnings. Rituxan, generic drug name rituximab, also known as Mabthera, was first a cancer agent. Rituxan has been approved to be used along with the drug methotr
談分子標靶藥物的作用機轉與副作用@ 阿水:: 痞客邦PIXNET :: - ur9s 談到分子標靶藥物,目前可說是很熱門的話題,其觀念就是使用單株抗體的治療, ... 現可分為2種:1種是認識細胞表面抗原的抗體,莫須瘤(Rituximab)屬於此類藥物。